All stories10
Showing 1–6 / 10CreatiPhage, the First Affiliated Hospital of XJTU Partner on Joint PhageBank to Combat Superbugs
XI'AN, China, July 27, 2026 — CreatiPhage Biotechnology Co., Ltd. (CreatiPhage) and the First Affiliated Hospital of Xi'an Jiaotong University (XJTU-FAH) have signed an agreement to jointly build a phagebank and launch a…
Read storyCreatiPhage Named a 2025 Chinese Healthcare Front-Runners Top 100 'Rising Star'
SHANGHAI, November 10, 2025 — CreatiPhage Biotechnology Co., Ltd. (CreatiPhage) has been selected as a 'Rising Star' on the 2025 Chinese Healthcare Front-Runners Top 100 list, recognizing its leading position and growth…
Read storyMeet CREATIPHAGE BIOTECHNOLOGY at 2025 EDRR Indonesia
From August 13–15, 2025, the 2nd International Emergency Disaster Reduction and Rescue Expo (EDRR Indonesia 2025) will be held at the Jakarta International Expo (JIEXPO) in Indonesia. Concurrently, a commemorative economic and…
Read storyMedical Breakthrough: "Phage Commandos" Breach Barriers in 72 Hours! 5-Month-Old with Superbug Colonization Gains New Hope
From his second month of life, coughing, fever, and wheezing relentlessly plagued Xiaoyu (Pseudonym). Instead of babbling in his mother’s arms, the infant spent 270 agonizing days in hospital ICUs. Due to an underlying…
Read storyCreatiPhage Completes Pre-A Financing, Accelerating the Commercialization of Phage Therapy
Recently, CreatiPhage (Shanghai) Biotechnology Co., Ltd. (referred to as "CreatiPhage") announced the completion of its Pre-A round of financing, exclusively invested by Xuhui Science and Technology Investment Private Fund…
Read storyCreatiPhage's 2023 Highlights
01 we valued interaction with the public releasing official promotional videos with CreatiPhage holding design contests with CreatiPhage launching the ChatPhage Forum CreatiPhage establishing a “100 Questions” column 02 we…
Read story





